Adolescents on neuroleptic medication: Is this population at risk for tardive dyskinesia?

Canadian Journal of Psychiatry

Volumn 43, Issue 6, 1998, Pages 629-631

  McDermid, Stephanie A ^a   Hood, Jane ^a   Bockus, Sandra ^a   D'Alessandro, Enzo ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Abnormal Involuntary Movement Scale (AIMS); Neuroleptic medication; Tardive dyskinesia

Indexed keywords

ANTIPARKINSON AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TARDIVE DYSKINESIA;

EID: 0031775081     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379804300613     Document Type: Article

References (8)

1. Casey DE. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophr Res 1991;4:109-20.
2. Jeste DV, Caligiuri MP. Tardive dyskinesia. Schizophr Bull 1993;19:303-15.
3. Muscettola G, Pampallona S, Barbato G, Casiello M, Bollini P. Persistent tardive dyskinesia: demographic and pharmacological risk factors. Acta Psychiatr Scand 1993;87:29-36.
4. Latimer PR. Tardive dyskinesia: a review. Can J Psychiatry 1995;40(2 Suppl):49S-54S.
5. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry 1997;36:835-43.
6. Dorevitch A, Meretyk I, Umansky Y, Galili-Weisstub E. Antipsychotic drugs and tardive dyskinesia: preliminary results in an adolescent psychiatric ward. J Clin Pharm Ther 1995;20:63-5.
7. Guy W. ECDEU assessment manual for psychopharmacology. Revised. Washington (DC): US Department of Health, Education and Welfare; 1976.
8. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982;39:486-7.